The DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: An update
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sullivan, T. J., Dairaghi, D. J., Krasinski, A., Miao, Z., Wang, Y., Zhao, B. N., Baumgart, T., Berahovich, R., Ertl, L. S., Pennell, A. M. K., et al. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.190918 · Cited by 11
RetractedBiochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849
Kyriakis, J. M., & Avruch, J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.807 · Cited by 3,382
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,086
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
Flier, J. S., Underhill, L. H., Brownlee, M., Cerami, A., & Vlassara, H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805193182007 · Cited by 2,511
Roux, P. P., & Blenis, J. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.2.320-344.2004 · Cited by 2,490
Requirement of JNK for Stress- Induced Activation of the Cytochrome c-Mediated Death Pathway
Tournier, C., Hess, P., Yang, D. D., Xu, J., Turner, T. K., Nimnual, A., Bar-Sagi, D., Jones, S. N., Flavell, R. A., & Davis, R. J. (2000) · Science · doi:10.1126/science.288.5467.870 · Cited by 1,728
Pathologic Classification of Diabetic Nephropathy
Tervaert, T. W. C., Mooyaart, A. L., Amann, K., Cohen, A. H., Cook, H. T., Drachenberg, C. B., Ferrario, F., Fogo, A. B., Haas, M., de Heer, E., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010010010 · Cited by 1,690
Singh, B. N., Shankar, S., & Srivastava, R. K. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.093 · Cited by 1,602
Jacinto, E., Facchinetti, V., Liu, D., Soto, N., Wei, S., Jung, S. Y., Huang, Q., Qin, J., & Su, B. (2006) · Cell · doi:10.1016/j.cell.2006.08.033 · Cited by 1,410
Advanced glycation end products in foods and a practical guide to their reduction in the diet
Uribarri, J., Woodruff, S., Goodman, S., Cai, W., Chen, X., Pyzik, R., Yong, A., Striker, G. E., & Vlassara, H. (2010) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2010.03.018 · Cited by 1,289
Holz, M. K., Ballif, B. A., Gygi, S. P., & Blenis, J. (2005) · Cell · doi:10.1016/j.cell.2005.10.024 · Cited by 1,262
Fingar, D. C., & Blenis, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207542 · Cited by 1,247
Susztak, K., Raff, A. C., Schiffer, M., & Böttinger, E. P. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0894 · Cited by 1,096
Ziyadeh, F. N., Hoffman, B. B., Han, D. C., Iglesias-de la Cruz, M. C., Hong, S. W., Isono, M., Chen, S., McGowan, T. A., & Sharma, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120055097 · Cited by 907
Structural Basis of Protein Kinase C Isoform Function
Steinberg, S. F. (2008) · Physiological Reviews · doi:10.1152/physrev.00034.2007 · Cited by 872
Homologs of gp91 phox : cloning and tissue expression of Nox3, Nox4, and Nox5
Cheng, G., Cao, Z., Xu, X., Meir, E. G. V., & Lambeth, J. D. (2001) · Gene · doi:10.1016/s0378-1119(01)00449-8 · Cited by 819
Specificity, diversity, and regulation in TGF-beta superfamily signaling.
Piek, E., HELDIN, C., & ten Dijke, P. (1999) · PubMed · Cited by 783
Sirolimus: its discovery, biological properties, and mechanism of action
Sehgal, S. N. (2003) · Transplantation Proceedings · doi:10.1016/s0041-1345(03)00211-2 · Cited by 779
Specificity, diversity, and regulation in TGF‐β superfamily signaling
PIEK, E., HELDIN, C., & DIJKE, P. T. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.15.2105 · Cited by 656
Relationship between Oxidative Stress and Inflammatory Cytokines in Diabetic Nephropathy
Elmarakby, A. A., & Sullivan, J. C. (2012) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00218.x · Cited by 641
The complexity of Raf-1 regulation
Morrison, D. K., & Cutler, R. E. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80060-9 · Cited by 635
Glycation and Diabetic Complications
Brownlee, M. (1994) · Diabetes · doi:10.2337/diab.43.6.836 · Cited by 632
TGF-β signaling by Smad proteins
Miyazono, K. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00025-8 · Cited by 626
Apoptosis in podocytes induced by TGF-β and Smad7
Schiffer, M., Bitzer, M., Roberts, I. S. D., Kopp, J. B., ten Dijke, P., Mundel, P., & Böttinger, E. P. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12367 · Cited by 598
Expression of connective tissue growth factor in human renal fibrosis
Ito, Y., Aten, J., Bende, R. J., Oemar, B. S., Rabelink, T. J., Weening, J. J., & Goldschmeding, R. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00820.x · Cited by 562
Role of mTOR in podocyte function and diabetic nephropathy in humans and mice
Gödel, M., Hartleben, B., Herbach, N., Liu, S., Zschiedrich, S., Lu, S., Debreczeni-Mór, A., Lindenmeyer, M. T., Rastaldi, M.-P., Hartleben, G., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44774 · Cited by 547
mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice
Inoki, K., Mori, H., Wang, J., Suzuki, T., Hong, S., Yoshida, S., Blattner, S. M., Ikenoue, T., Rüegg, M. A., Hall, M. N., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44771 · Cited by 538
The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity
Shahbazian, D., Roux, P. P., Mieulet, V., Cohen, M. S., Raught, B., Taunton, J., Hershey, J. W., Blenis, J., Pende, M., & Sonenberg, N. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601166 · Cited by 531
Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies
Sansone, P., & Bromberg, J. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.8907 · Cited by 515
Nox4 NAD(P)H Oxidase Mediates Hypertrophy and Fibronectin Expression in the Diabetic Kidney
Gorin, Y., Block, K., Hernandez, J., Bhandari, B., Wagner, B., Barnes, J. L., & Abboud, H. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502412200 · Cited by 497
Wang, W., Wang, Y., Long, J., Wang, J., Haudek, S. B., Overbeek, P., Chang, B. H. J., Schumacker, P. T., & Danesh, F. R. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.009 · Cited by 476
Histopathology of Diabetic Nephropathy
Fioretto, P., & Mauer, M. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.01.012 · Cited by 467
Bolton, W. K., Cattran, D. C., Williams, M. E., Adler, S. G., Appel, G. B., Cartwright, K., Foiles, P. G., Freedman, B. I., Raskin, P., Ratner, R. E., et al. (2004) · American Journal of Nephrology · doi:10.1159/000075627 · Cited by 461
Gill, P. S., & Wilcox, C. S. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1597 · Cited by 457
Pharmacological inhibitors of MAPK pathways
English, J. M., & Cobb, M. H. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01865-4 · Cited by 447
TGF-β signaling by Smad proteins
Miyazono, K., Ten Dijke, P., & Heldin, C.-H. (2000) · Advances in Immunology · doi:10.1016/s0065-2776(00)75003-6 · Cited by 433
Kolm-Litty, V, Sauer, U., Nerlich, A., Lehmann, R., & Schleicher, E. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119875 · Cited by 430
The role of MAPK signalling pathways in the response to endoplasmic reticulum stress
Darling, N. J., & Cook, S. J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.01.009 · Cited by 399
Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways
Igarashi, M., Wakasaki, H., Takahara, N., Ishii, H., Jiang, Z.-Y., Yamauchi, T., Kuboki, K., Meier, M., Rhodes, C. J., & King, G. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3326 · Cited by 386
Toll-Like Receptor 4 Promotes Tubular Inflammation in Diabetic Nephropathy
Lin, M., Yiu, W. H., Wu, H. J., Chan, L. Y. Y., Leung, J. C. K., Au, W. S., Chan, K. W., Lai, K. N., & Tang, S. C. W. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111210 · Cited by 386
The NOX toolbox: validating the role of NADPH oxidases in physiology and disease
Altenhöfer, S., Kleikers, P. W. M., Radermacher, K. A., Scheurer, P., Rob Hermans, J. J., Schiffers, P., Ho, H., Wingler, K., & Schmidt, H. H. H. W. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1010-9 · Cited by 371
Restraining PI3K: mTOR signalling goes back to the membrane
Harrington, L. S., Findlay, G. M., & Lamb, R. F. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.11.003 · Cited by 366
Podocyte as the Target for Aldosterone: Roles of Oxidative Stress and Sgk1
Shibata, S., Nagase, M., Yoshida, S., Kawachi, H., & Fujita, T. (2007) · Hypertension · doi:10.1161/01.hyp.0000255636.11931.a2 · Cited by 362
Wolf, G. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01429.x · Cited by 360
Production and physiological actions of anandamide in the vasculature of the rat kidney.
Deutsch, D. G., Goligorsky, M. S., Schmid, P. C., Krebsbach, R. J., Schmid, H. H., Das, S. K., Dey, S. K., Arreaza, G., Thorup, C., Stefano, G., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119677 · Cited by 360
Smith, E. M., Finn, S. G., Tee, A. R., Browne, G. J., & Proud, C. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414499200 · Cited by 355
Thallas-Bonke, V., Thorpe, S. R., Coughlan, M. T., Fukami, K., Yap, F. Y. T., Sourris, K. C., Penfold, S. A., Bach, L. A., Cooper, M. E., & Forbes, J. M. (2008) · Diabetes · doi:10.2337/db07-1119 · Cited by 345
Li, Y., Kang, Y. S., Dai, C., Kiss, L. P., Wen, X., & Liu, Y. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070057 · Cited by 338
Hexosamines and Insulin Resistance
McClain, D. A., & Crook, E. D. (1996) · Diabetes · doi:10.2337/diab.45.8.1003 · Cited by 334
Berthier, C. C., Zhang, H., Schin, M., Henger, A., Nelson, R. G., Yee, B., Boucherot, A., Neusser, M. A., Cohen, C. D., Carter-Su, C., et al. (2009) · Diabetes · doi:10.2337/db08-1328 · Cited by 317
The Effect of Ruboxistaurin on Nephropathy in Type 2 Diabetes
Tuttle, K. R., Bakris, G. L., Toto, R. D., McGill, J. B., Hu, K., & Anderson, P. W. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2686 · Cited by 300
Aiding and abetting roles of NOX oxidases in cellular transformation
Block, K., & Gorin, Y. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3339 · Cited by 297
Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal disease
Guan, Y., & Breyer, M. D. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00766.x · Cited by 295
Yamagishi, S.-I., Maeda, S., Matsui, T., Ueda, S., Fukami, K., & Okuda, S. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.03.014 · Cited by 294
Control of the eukaryotic cell cycle by MAP kinase signaling pathways
Wilkinson, M. G., & Millar, J. B. A. (2000) · The FASEB Journal · doi:10.1096/fj.00-0102rev · Cited by 280
Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells
Gorin, Y., Ricono, J. M., Kim, N.-H., Bhandari, B., Choudhury, G. G., & Abboud, H. E. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00414.2002 · Cited by 277
Moriwaki, Y., Yamamoto, T., Shibutani, Y., Aoki, E., Tsutsumi, Z., Takahashi, S., Okamura, H., Koga, M., Fukuchi, M., & Hada, T. (2003) · Metabolism · doi:10.1053/meta.2003.50096 · Cited by 270
Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential
Bogoyevitch, M. A., Boehm, I., Oakley, A., Ketterman, A. J., & Barr, R. K. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.11.016 · Cited by 266
Polyol Accumulation in Galactosemic and Diabetic Rats: Control by an Aldose Reductase Inhibitor
Dvornik, D., Simard-Duquesne, N., Krami, M., Sestanj, K., Gabbay, K. H., Kinoshita, J. H., Varma, S. D., & Merola, L. O. (1973) · Science · doi:10.1126/science.182.4117.1146 · Cited by 265
Latency, activation, and binding proteins of TGF-?
Koli, K., Saharinen, J., Hyyti�inen, M., Penttinen, C., & Keski-Oja, J. (2001) · Microscopy Research and Technique · doi:10.1002/1097-0029(20010215)52:4<354::aid-jemt1020>3.0.co;2-g · Cited by 261
SUZUKI, D., MIYATA, T., SAOTOME, N., HORIE, K., INAGI, R., YASUDA, Y., UCHIDA, K., IZUHARA, Y., YAGAME, M., SAKAI, H., et al. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v104822 · Cited by 254
Haneda, M., Araki, S.-I., Togawa, M., Sugimoto, T., Motohide, I., & Kikkawa, R. (1997) · Diabetes · doi:10.2337/diab.46.5.847 · Cited by 248
Chen, Z., Zhang, D., Yue, F., Zheng, M., Kovacevic, Z., & Richardson, D. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.350470 · Cited by 248
Avosentan Reduces Albumin Excretion in Diabetics with Macroalbuminuria
Wenzel, R. A. A. R., Littke, T., Kuranoff, S., Ju[Combining Diaeresis]rgens, C., Bruck, H., Ritz, E., Philipp, T., & Mitchell, A. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008050482 · Cited by 246
Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats
Lloberas, N., Cruzado, J. M., Franquesa, M., Herrero-Fresneda, I., Torras, J., Alperovich, G., Rama, I., Vidal, A., & Grinyó, J. M. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050549 · Cited by 245
p38α Mitogen-activated Protein Kinase Sensitizes Cells to Apoptosis Induced by Different Stimuli
Porras, A., Zuluaga, S., Black, E., Valladares, A., Alvarez, A. M., Ambrosino, C., Benito, M., & Nebreda, A. R. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-08-0592 · Cited by 227
Diabetic nephropathy: Prevention and treatment
Parving, H.-H. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00020.x · Cited by 226
The Protective Role of Smad7 in Diabetic Kidney Disease: Mechanism and Therapeutic Potential
Chen, H. Y., Huang, X. R., Wang, W., Li, J. H., Heuchel, R. L., Chung, A. C. K., & Lan, H. Y. (2011) · Diabetes · doi:10.2337/db10-0403 · Cited by 225
Mukhopadhyay, P., Rajesh, M., Pan, H., Patel, V., Mukhopadhyay, B., Bátkai, S., Gao, B., Haskó, G., & Pacher, P. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.11.022 · Cited by 220
Can We Target Tubular Damage to Prevent Renal Function Decline in Diabetes?
Bonventre, J. V. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.07.008 · Cited by 219
Petersen, M., Thorikay, M., Deckers, M., van Dinther, M., Grygielko, E. T., Gellibert, F., de Gouville, A. C., Huet, S., ten Dijke, P., & Laping, N. J. (2008) · Kidney International · doi:10.1038/sj.ki.5002717 · Cited by 215
Packham, D. K., Alves, T. P., Dwyer, J. P., Atkins, R., de Zeeuw, D., Cooper, M., Shahinfar, S., Lewis, J. B., & Lambers Heerspink, H. J. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.09.017 · Cited by 205
Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria
Adler, S. G., Schwartz, S., Williams, M. E., Arauz-Pacheco, C., Bolton, W. K., Lee, T., Li, D., Neff, T. B., Urquilla, P. R., & Sewell, K. L. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09321209 · Cited by 204
Zheng, J., Inoguchi, T., Sasaki, S., Maeda, Y., McCarty, M. F., Fujii, M., Ikeda, N., Kobayashi, K., Sonoda, N., & Takayanagi, R. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00648.2011 · Cited by 201
Moon, J.-A., Kim, H.-T., Cho, I.-S., Sheen, Y. Y., & Kim, D.-K. (2006) · Kidney International · doi:10.1038/sj.ki.5001775 · Cited by 197
Su, Z., Zimpelmann, J., & Burns, K. D. (2006) · Kidney International · doi:10.1038/sj.ki.5001509 · Cited by 196
Potential approaches to reverse or repair renal fibrosis
Tampe, D., & Zeisberg, M. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.14 · Cited by 195
Adhikary, L., Chow, F., Nikolic-Paterson, D. J., Stambe, C., Dowling, J., Atkins, R. C., & Tesch, G. H. (2004) · Diabetologia · doi:10.1007/s00125-004-1437-0 · Cited by 195
Ohshiro, Y., Ma, R. C., Yasuda, Y., Hiraoka-Yamamoto, J., Clermont, A. C., Isshiki, K., Yagi, K., Arikawa, E., Kern, T. S., & King, G. L. (2006) · Diabetes · doi:10.2337/db06-0895 · Cited by 188
Cai, W., He, J. C., Zhu, L., Chen, X., Zheng, F., Striker, G. E., & Vlassara, H. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080152 · Cited by 186
Accelerated diabetic glomerulopathy in galectin‐3/AGE receptor 3 knockout mice
PUGLIESE, G., PRICCI, F., IACOBINI, C., LETO, G., AMADIO, L., BARSOTTI, P., FRIGERI, L., HSU, D. K., VLASSARA, H., LIU, F.-T., et al. (2001) · The FASEB Journal · doi:10.1096/fj.01-0006com · Cited by 184
Aldose reductase: new insights for an old enzyme
Ramana, K. V. (2011) · bmc · doi:10.1515/bmc.2011.002 · Cited by 180
Ma, F. Y., Flanc, R. S., Tesch, G. H., Han, Y., Atkins, R. C., Bennett, B. L., Friedman, G. C., Fan, J.-H., & Nikolic-Paterson, D. J. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006060604 · Cited by 179
Wang, X., Shaw, S., Amiri, F., Eaton, D. C., & Marrero, M. B. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3505 · Cited by 176
Singh, V. P., Baker, K. M., & Kumar, R. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.91493.2007 · Cited by 176
Rapamycin Prevents Early Steps of the Development of Diabetic Nephropathy in Rats
Yang, Y., Wang, J., Qin, L., Shou, Z., Zhao, J., Wang, H., Chen, Y., & Chen, J. (2007) · American Journal of Nephrology · doi:10.1159/000106782 · Cited by 174
Ishibashi, Y., Matsui, T., Takeuchi, M., & Yamagishi, S.-I. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.075 · Cited by 173
Molecular mechanisms of hypertension: role of Nox family NADPH oxidases
Sedeek, M., Hébert, R. L., Kennedy, C. R., Burns, K. D., & Touyz, R. M. (2009) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0b013e32832923c3 · Cited by 171
Chander, P. N., Gealekman, O., Brodsky, S. V., Elitok, S., Tojo, A., Crabtree, M., Gross, S. S., & Goligorsky, M. S. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000135971.88164.2c · Cited by 171
Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility
Mott, J. D., Khalifah, R. G., Nagase, H., Shield, C. F., Hudson, J. K., & Hudson, B. G. (1997) · Kidney International · doi:10.1038/ki.1997.455 · Cited by 170
Diabetic Nephropathy: Worldwide epidemic and effects of current treatment on natural history
Rossing, P. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0083-y · Cited by 170
Transforming Growth Factor- β Activation in the Lung: Focus on Fibrosis and Reactive Oxygen Species
Koli, K., Myllärniemi, M., Keski-Oja, J., & Kinnula, V. L. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1914 · Cited by 168
Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes
Devaraj, S., Tobias, P., & Jialal, I. (2011) · Cytokine · doi:10.1016/j.cyto.2011.03.023 · Cited by 168
Cai, W., He, J. C., Zhu, L., Lu, C., & Vlassara, H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600362103 · Cited by 163
Mukhopadhyay, P., Pan, H., Rajesh, M., Bátkai, S., Patel, V., Harvey-White, J. D., Mukhopadhyay, B., Haskó, G., Gao, B., Mackie, K., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00769.x · Cited by 160
Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes
Sedeek, M., Gutsol, A., Montezano, A. C., Burger, D., Nguyen Dinh Cat, A., Kennedy, C. R. J., Burns, K. D., Cooper, M. E., Jandeleit-Dahm, K., Page, P., et al. (2013) · Clinical Science · doi:10.1042/cs20120330 · Cited by 159
mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression
Huber, T. B., Walz, G., & Kuehn, E. W. (2010) · Kidney International · doi:10.1038/ki.2010.457 · Cited by 157
Ojima, A., Ishibashi, Y., Matsui, T., Maeda, S., Nishino, Y., Takeuchi, M., Fukami, K., & Yamagishi, S.-I. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.09.016 · Cited by 156
Seldon, M. P., Silva, G. P. D. L., Pejanovic, N., Larsen, R., Grégoire, I. P., Filipe, J. C.-R., Anrather, J., & Soares, M. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7840 · Cited by 154
Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy
Sakai, N., Wada, T., Furuichi, K., Iwata, Y., Yoshimoto, K., Kitagawa, K., Kokubo, S., Kobayashi, M., Hara, A., Yamahana, J., et al. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.08.039 · Cited by 152
Chuang, P. Y., Yu, Q., Fang, W., Uribarri, J., & He, J. C. (2007) · Kidney International · doi:10.1038/sj.ki.5002456 · Cited by 152
Wang, D., Dai, C., Li, Y., & Liu, Y. (2011) · Kidney International · doi:10.1038/ki.2011.255 · Cited by 151
Kang, Y. S., Li, Y., Dai, C., Kiss, L. P., Wu, C., & Liu, Y. (2010) · Kidney International · doi:10.1038/ki.2010.137 · Cited by 150
Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy
Barutta, F., Corbelli, A., Mastrocola, R., Gambino, R., Marzo, V. D., Pinach, S., Rastaldi, M. P., Perin, P. C., & Gruden, G. (2010) · Diabetes · doi:10.2337/db09-1336 · Cited by 149
Activation of the TGF- β/Smad signaling pathway in focal segmental glomerulosclerosis
Kim, J. H., Kim, B. K., Moon, K. C., Hong, H. K., & Lee, H. S. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00288.x · Cited by 148
Alter, M., Ott, I. M., von Websky, K., Tsuprykov, O., Sharkovska, Y., Relle, K., Raila, J., Henze, A., Klein, T., & Hocher, B. (2012) · Kidney & Blood Pressure Research · doi:10.1159/000341487 · Cited by 147
Nutrient sensing and metabolic decisions
Lindsley, J. E., & Rutter, J. P. (2004) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpc.2004.06.014 · Cited by 147
Accelerated Diabetic Nephropathy in Mice Lacking the Peroxisome Proliferator–Activated Receptor α
Park, C. W., Kim, H. W., Ko, S., Chung, H. W., Lim, S. W., Yang, C. W., Chang, Y. S., Sugawara, A., Guan, Y., & Breyer, M. D. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1329 · Cited by 144
Farvid, M. S., Jalali, M., Siassi, F., & Hosseini, M. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2458 · Cited by 143
Wahab, N. A., Schaefer, L., Weston, B. S., Yiannikouris, O., Wright, A., Bábelová, A., Schaefer, R. M., & Mason, R. M. (2005) · Diabetologia · doi:10.1007/s00125-005-0006-5 · Cited by 139
Menne, J., Park, J.-K., Boehne, M., Elger, M., Lindschau, C., Kirsch, T., Meier, M., Gueler, F., Fiebeler, A., Bahlmann, F. H., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2101 · Cited by 138
Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose
Amiri, F., Shaw, S., Wang, X., Tang, J., Waller, J. L., Eaton, D. C., & Marrero, M. B. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00311.x · Cited by 134
Ko, G.-J., Kang, Y. S., Han, S. Y., Lee, M. H., Song, H. K., Han, K. H., Kim, H. K., Han, J., & Cha, D. R. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn157 · Cited by 132
Inhibition of Plasminogen Activator Inhibitor-1
Izuhara, Y., Takahashi, S., Nangaku, M., Takizawa, S., Ishida, H., Kurokawa, K., de Strihou, C. V. Y., Hirayama, N., & Miyata, T. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.157479 · Cited by 132
Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells
Stielow, C., Catar, R. A., Müller, G. M., Wingler, K., Scheurer, P., Schmidt, H. H. H. W., & Morawietz, H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.114 · Cited by 127
Rane, M. J., Song, Y., Jin, S., Barati, M. T., Wu, R., Kausar, H., Tan, Y., Wang, Y., Zhou, G., Klein, J. B., et al. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00032.2009 · Cited by 126
ERK and p38 mediate high-glucose-induced hypertrophy and TGF-β expression in renal tubular cells
Fujita, H., Omori, S., Ishikura, K., Hida, M., & Awazu, M. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00351.2002 · Cited by 126
Janiak, P., Poirier, B., Bidouard, J., Cadrouvele, C., Pierre, F., Gouraud, L., Barbosa, I., Dedio, J., Maffrand, J., Fur, G. L., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002540 · Cited by 124
Regulation of Elongation Phase of mRNA Translation in Diabetic Nephropathy
Sataranatarajan, K., Mariappan, M. M., Lee, M. J., Féliers, D., Choudhury, G. G., Barnes, J. L., & Kasinath, B. S. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070412 · Cited by 121
Isono, M., de la Cruz, M. D. C. I., Chen, S., Hong, S. W., & Ziyadeh, F. N. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11122222 · Cited by 121
Moghaddam, H. K., Baluchnejadmojarad, T., Roghani, M., Khaksari, M., Norouzi, P., Ahooie, M., & Mahboobi, F. S. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8559-7 · Cited by 120
Xia, L., Wang, H., Goldberg, H. J., Munk, S., Fantus, I. G., & Whiteside, C. I. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00119.2005 · Cited by 118
Pyridoxamine: The Many Virtues of a Maillard Reaction Inhibitor
Voziyan, P., & Hudson, B. G. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.093 · Cited by 117
Manna, P., & Kalita, J. (2016) · Nutrition · doi:10.1016/j.nut.2016.01.011 · Cited by 117
Self-citationKnockdown of Stat3 activity in vivo prevents diabetic glomerulopathy
Lu, T.-C., Wang, Z., Feng, X., Chuang, P. Y., Fang, W. Y., Shen, Y., Levy, D. E., Xiong, H., Chen, N., & He, C. (2009) · Kidney International · doi:10.1038/ki.2009.98 · Cited by 116
Pan, Y., Zhang, X., Wang, Y., Cai, L., Ren, L., Tang, L., Wang, J., Zhao, Y., Wang, Y., Liu, Q., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079084 · Cited by 113
Lim, A. K. H., Nikolic‐Paterson, D. J., Ma, F. Y., Ozols, E., Thomas, M. C., Flavell, R. A., Davis, R. J., & Tesch, G. H. (2008) · Diabetologia · doi:10.1007/s00125-008-1215-5 · Cited by 113
Izuhara, Y., Yamaoka, N., Kodama, H., Dan, T., Takizawa, S., Hirayama, N., Meguro, K., de Strihou, C. V. Y., & Miyata, T. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.272 · Cited by 111
High glucose accelerates MCP-1 production via p38 MAPK in vascular endothelial cells
Takaishi, H., Taniguchi, T., Takahashi, A., Ishikawa, Y., & Yokoyama, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00712-5 · Cited by 111
Thallas‐Bonke, V., Jha, J. C., Gray, S. P., Barit, D., Haller, H. G., Schmidt, H. H. H. W., Coughlan, M. T., Cooper, M. E., Forbes, J. M., & Jandeleit-Dahm, K. A. M. (2014) · Physiological Reports · doi:10.14814/phy2.12192 · Cited by 111
Advanced Glycation End Products and Diabetic Nephropathy
Thomas, M. C., Forbes, J. M., & Cooper, M. E. (2005) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000178769.52610.69 · Cited by 110
Glomerular and tubular induction of the transcription factor c‐Jun in human renal disease
de Borst, M. H., Prakash, J., Melenhorst, W. B. W. H., van den Heuvel, M. C., Kok, R. J., Navis, G. J., & van Goor, H. (2007) · The Journal of Pathology · doi:10.1002/path.2228 · Cited by 110
Alkhalaf, A., Klooster, A., van Oeveren, W., Achenbach, U., Kleefstra, N., Slingerland, R. J., Mijnhout, G. S., Bilo, H. J. G., Gans, R. O. B., Navis, G., et al. (2010) · Diabetes Care · doi:10.2337/dc09-2241 · Cited by 108
PKC-β1 Mediates Glucose-Induced Akt Activation and TGF-β1 Upregulation in Mesangial Cells
Wu, D., Peng, F.-F., Zhang, B., Ingram, A. J., Kelly, D. J., Gilbert, R. E., Gao, B., & Krepinsky, J. C. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008040445 · Cited by 108
Wilmer, W. A., Dixon, C. L., & Hebert, C. L. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.060003858.x · Cited by 107
Hayashi, K., Ozawa, Y., Fujiwara, K., Wakino, S., Kumagai, H., & Saruta, T. (2003) · American Journal of Nephrology · doi:10.1159/000072054 · Cited by 103
Gene expression of adenosine receptors along the nephron
Vitzthum, H., Weiss, B., Bachleitner, W., Krämer, B. K., & Kurtz, A. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00490.x · Cited by 99
Carbonyl Stress in the Pathogenesis of Diabetic Nephropathy.
SUZUKI, D., & Miyata, T. (1999) · Internal Medicine · doi:10.2169/internalmedicine.38.309 · Cited by 99
Yoo, K. H., Thornhill, B. A., Forbes, M. S., Coleman, C. M., Marcinko, E. S., Liaw, L., & Chevalier, R. L. (2006) · Kidney International · doi:10.1038/sj.ki.5000357 · Cited by 98
Meyers, M. J., Arhancet, G. B., Hockerman, S. L., Chen, X., Long, S. A., Mahoney, M. W., Rico, J. R., Garland, D. J., Blinn, J. R., Collins, J. T., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100505n · Cited by 97
Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease
Lee, H. S. (2011) · Cell and Tissue Research · doi:10.1007/s00441-011-1169-7 · Cited by 97
Glomerular expression of p27Kip1 in diabetic db/db mouse: Role of hyperglycemia
Wolf, G., Schroeder, R., Thaiss, F., Ziyadeh, F. N., Helmchen, U. M., & Stahl, R. A. K. (1998) · Kidney International · doi:10.1111/j.1523-1755.1998.00829.x · Cited by 96
Shankland, S. J., Pippin, J. W., Pichler, R. H., Gordon, K. L., Friedman, S. L., Gold, L. I., Johnson, R. J., & Couser, W. G. (1996) · Kidney International · doi:10.1038/ki.1996.294 · Cited by 95
Recent advances in the regulation of the TOR pathway by insulin and nutrients
Avruch, J., Lin, Y., Long, X., Murthy, S., & Ortiz-Vega, S. (2004) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200501000-00010 · Cited by 92
Utsugi, M., Dobashi, K., Ishizuka, T., Masubuchi, K., Shimizu, Y., Nakazawa, T., & Mori, M. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.4892 · Cited by 89
Lakshmanan, A. P., Watanabe, K., Thandavarayan, R. A., Sari, F. R., Harima, M., Giridharan, V. V., Soetikno, V., Kodama, M., & Aizawa, Y. (2011) · Free Radical Research · doi:10.3109/10715762.2011.560149 · Cited by 87
S6 kinase 1 knockout inhibits uninephrectomy- or diabetes-induced renal hypertrophy
Chen, J., Chen, J., Thomas, G., Kozma, S. C., & Harris, R. C. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00186.2009 · Cited by 85
Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation
Farvid, M. S., Homayouni, F., Amiri, Z., & Adelmanesh, F. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.03.016 · Cited by 85
Wolf, G., Schanze, A., Stahl, R. A. K., Shankland, S. J., & Amann, K. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00570.x · Cited by 84
Gava, E., Samad-Zadeh, A., Zimpelmann, J., Bahramifarid, N., Kitten, G. T., Santos, R. A. S., Touyz, R. M., & Burns, K. D. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn736 · Cited by 84
Zhang, H., Jia, Y., Cooper, J. J., Hale, T. C., Zhang, Z., & Elbein, S. C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031286 · Cited by 82
Kimoto, K., Nakatsuka, K., Matsuo, N., & Yoshioka, H. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-1276 · Cited by 82
Zhang, S., Zhang, Y., Wei, X., Zhen, J., Wang, Z., Li, M., Miao, W., Ding, H., Du, P., Zhang, W., et al. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.08.003 · Cited by 81
Nakano, S., Kobayashi, N., Yoshida, K., Tomoyuki, O. H. N. O., & Matsuoka, H. (2005) · Hypertension Research · doi:10.1291/hypres.28.925 · Cited by 81
Ishibashi, Y., Yamagishi, S., Matsui, T., Ohta, K., Tanoue, R., Takeuchi, M., Ueda, S., Nakamura, K., & Okuda, S. (2012) · Metabolism · doi:10.1016/j.metabol.2012.01.006 · Cited by 80
Mishra, A., Bhatti, R., Singh, A., & Ishar, M. P. S. (2009) · Planta Medica · doi:10.1055/s-0029-1186237 · Cited by 78
Cheng, D. W., Jiang, Y., Shalev, A., Kowluru, R., Crook, E. D., & Singh, L. P. (2006) · Archives of Physiology and Biochemistry · doi:10.1080/13813450601093518 · Cited by 78
Role of Advanced Glycation End Products (AGEs) in Thrombogenic Abnormalities in Diabetes
Takenaka, K., Yamagishi, S., Matsui, T., Nakamura, K., & Imaizumi, T. (2006) · Current Neurovascular Research · doi:10.2174/156720206775541804 · Cited by 77
Huang, J., Guh, J., Hung, W., Yang, M., Lai, Y., Chen, H., & Chuang, L. (1999) · Biochemical Journal · doi:10.1042/bj3420231 · Cited by 74
Opportunity Nox: The Future of NADPH Oxidases as Therapeutic Targets in Cardiovascular Disease
Streeter, J., Thiel, W. H., Brieger, K., & Miller, F. J. (2012) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2011.00310.x · Cited by 73
Liu, Y.-W., Zhu, X., Zhang, L., Lu, Q., Wang, J.-Y., Zhang, F., Guo, H., Yin, J.-L., & Yin, X.-X. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.08.029 · Cited by 72
Asanuma, K., Shirato, I., Ishidoh, K., et al. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00539.x · Cited by 69
Role of the AGE crosslink breaker, alagebrium, as a renoprotective agent in diabetes
Coughlan, M. T., Forbes, J. M., & Cooper, M. E. (2007) · Kidney International · doi:10.1038/sj.ki.5002387 · Cited by 68
Hu, Z., Ren, L., Wang, C., Liu, B., & Song, G. (2012) · Kidney & Blood Pressure Research · doi:10.1159/000341485 · Cited by 68
A pathogenic role for JNK signaling in experimental anti-GBM glomerulonephritis
Flanc, R. S., Ma, F. Y., Tesch, G. H., Han, Y., Atkins, R. C., Bennett, B. L., Friedman, G. C., Fan, J., & Nikolic‐Paterson, D. J. (2007) · Kidney International · doi:10.1038/sj.ki.5002404 · Cited by 68
Irita, J., Okura, T., Jotoku, M., Nagao, T., Enomoto, D., Kurata, M., Desilva, V. R., Miyoshi, K., Matsui, Y., Uede, T., et al. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00557.2010 · Cited by 67
Ijaz, A., Tejada, T., Catanuto, P., Xia, X., Elliot, S. J., Lenz, O., Jauregui, A. N., Saenz, M. O., Molano, R. D., Pileggi, A., et al. (2008) · Kidney International · doi:10.1038/ki.2008.559 · Cited by 64
Park, S.-K., Dahmer, M. K., & Quasney, M. W. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000339068 · Cited by 63
Hayashida, T., & Schnaper, H. W. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000133198.74973.60 · Cited by 63
Kuo, C.-W., Shen, C., Tung, Y., Chen, H., Chen, Y., Chang, W.-H., Cheng, K.-C., Yang, S., & Chen, C. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.04.018 · Cited by 62
Wolf, G., Reinking, R. R., Zahner, G., Stahl, R. A. K., & Shankland, S. J. (2003) · Diabetologia · doi:10.1007/s00125-003-1163-z · Cited by 62
c-Jun NH2-Terminal Kinase Is Crucially Involved in Renal Tubulo-Interstitial Inflammation
de Borst, M. H., Prakash, J., Sandovici, M., Klok, P. A., Hamming, I., Kok, R. J., Navis, G., & van Goor, H. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.154179 · Cited by 62
Kumar, B., Gupta, S. K., Srinivasan, B. P., Nag, T. C., Srivastava, S., & Saxena, R. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.02.007 · Cited by 61
Meier, M., Menne, J., Park, J.-K., Holtz, M., Gueler, F., Kirsch, T., Schiffer, M., Mengel, M., Lindschau, C., Leitges, M., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005070694 · Cited by 61
Chen, Y.-J., & Quilley, J. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.129197 · Cited by 59
Effect of green tea on kidney tubules of diabetic rats
Renno, W. M., Abdeen, S. M., Alkhalaf, M., & Asfar, S. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114508911533 · Cited by 59
Lakshmanan, A. P., Thandavarayan, R. A., Watanabe, K., Sari, F. R., Harima, M., Giridharan, V. V., Sukumaran, V., Soetikno, V., Arumugam, S., Suzuki, K., et al. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.041 · Cited by 57
Chen, L., Zhang, J., & Wang, B. (2006) · Vascular Pharmacology · doi:10.1016/j.vph.2006.01.004 · Cited by 55
Effect of cinnamon and its procyanidin-B2 enriched fraction on diabetic nephropathy in rats
Muthenna, P., Raghu, G., Kumar, P. A., Surekha, M. V., & Reddy, G. B. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.08.013 · Cited by 55
Zhang, S., Tang, S., Chen, X., Filep, J. G., Ingelfinger, J. R., & Chan, J. S. D. (2000) · Endocrinology · doi:10.1210/endo.141.12.7844 · Cited by 55
Plumbagin Ameliorates Diabetic Nephropathy via Interruption of Pathways that Include NOX4 Signalling
Yong, R., Chen, X., Shen, S., Vijayaraj, S. L., Ma, Q., Pollock, C. A., & Saad, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073428 · Cited by 50
Long-Term Treatment of Sirolimus but Not Cyclosporine Ameliorates Diabetic Nephropathy in the Rat
Wittmann, S., Daniel, C., Stief, A., Vogelbacher, R., Amann, K., & Hugo, C. (2009) · Transplantation · doi:10.1097/tp.0b013e3181a192bd · Cited by 50
The Role of Sulodexide in the Treatment of Diabetic Nephropathy
Weiss, R., Niecestro, R., & Raz, I. (2007) · Drugs · doi:10.2165/00003495-200767180-00004 · Cited by 48
Vogt, L., Chiurchiu, C. R., Chadha‐Boreham, H., Danaietash, P., Dingemanse, J., Hadjadj, S., Krum, H., Navis, G., Neuhart, E., Parvanova, A. I., et al. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.149559 · Cited by 48
Sen, U., Rodriguez, W. E., Tyagi, N., Kumar, M., Kundu, S., & Tyagi, S. C. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90534.2008 · Cited by 45
Jung, D.-S., Li, J. J., Kwak, S.-J., Lee, S. H., Park, J., Song, Y. S., Yoo, T., Han, S. H., Lee, J. E., Kim, D. K., et al. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00624.2007 · Cited by 44
Novel Insights into the Relationship Between Glomerular Pathology and Progressive Kidney Disease
Satirapoj, B., Nast, C. C., & Adler, S. G. (2012) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2011.12.001 · Cited by 43
Challenges ahead in signal transduction: MAPK as an example
Kiel, C., & Serrano, L. G. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.10.004 · Cited by 43
Suzuki, H., Uchida, K., Nitta, K., & Nihei, H. (2004) · Clinical and Experimental Nephrology · doi:10.1007/s10157-004-0297-8 · Cited by 39
Lim, A. K. H., Ma, F. Y., Nikolic‐Paterson, D. J., Ozols, E., Young, M. J., Bennett, B. L., Friedman, G. C., & Tesch, G. H. (2011) · American Journal of Nephrology · doi:10.1159/000331058 · Cited by 38
Wang, L., Matsushita, K., Araki, I., & Takeda, M. (2002) · The Nephron journals/Nephron journals · doi:10.1159/000057616 · Cited by 38
Okamoto, M., Fuchigami, M., Suzuki, T., & Watanabe, N. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00528 · Cited by 37
TGF-β1 Regulates the PINCH-1–Integrin-Linked Kinase–α-Parvin Complex in Glomerular Cells
Jung, K. Y., Chen, K., Kretzler, M., & Wu, C. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050421 · Cited by 37
p38 MAPK inhibition reduces diabetes-induced impairment of wound healing
Higgins, L. (2009) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s5859 · Cited by 36
Cited by
Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
Ye, F., Dewanjee, S., Li, Y., Jha, N. K., Chen, Z.-S., Kumar, A., Vishakha, Behl, T., Jha, S. K., & Tang, H. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01805-y · Cited by 554
Self-citationChen, L., Yang, T., Lu, D.-W., Zhao, H., Feng, Y.-L., Chen, H., Chen, D.-Q., Vaziri, N. D., & Zhao, Y.-Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.090 · Cited by 359
Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets
Dewanjee, S., Das, S., Das, A. K., Bhattacharjee, N., Dihingia, A., Dua, T. K., Kalita, J., & Manna, P. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.06.034 · Cited by 300
Self-citationDiabetic nephropathy – is this an immune disorder?
Tesch, G. H. (2017) · Clinical Science · doi:10.1042/cs20160636 · Cited by 264
Huang, K., Gao, X., & Wei, W. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.09.042 · Cited by 155
Metadata
- Authors
- Bhattacharjee, N., Barma, S., Konwar, N., Dewanjee, S., & Manna, P.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 791
- Pages
- 8-24
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W2512180685
- Cited by
- 271
- References
- 223
- FWCI
- 23.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.